1-7 of 7
Franziska Brauneck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The PTPN2/PTPN1 Inhibitor Abbv-CLS-484 Augments Immune Responses Against Leukemic Blasts and Impedes Leukemia Cell Proliferation in AML Alone and in Combination with Venetoclax

Niklas Kruppa, Moritz Kruppa, Jana Muschhammer, Nadine Felber, Franziska Brauneck, Franziska Modemann, Jasmin Wellbrock, Walter Fiedler
Journal: Blood
Blood (2024) 144 (Supplement 1): 1374.
https://doi.org/10.1182/blood-2024-201504
Published: 2024
Journal Articles

CD39 Is Predominantly Expressed in Adverse AML Patients and Blockade By a New Anti-CD39 Nanobody Increases Lysis of AML Blasts

Franziska Brauneck, Stefan Menzel, Niklas Kruppa, Fritz Koch-Nolte, Walter Fiedler, Jasmin Wellbrock
Journal: Blood
Blood (2024) 144 (Supplement 1): 1397.
https://doi.org/10.1182/blood-2024-206914
Published: 2024
Journal Articles

Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis

Franziska Brauneck, Brit Fischer, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Friedrich Haag, Christin Ackermann, Walter Fiedler
Journal: Blood
Blood (2021) 138 (Supplement 1): 3351.
https://doi.org/10.1182/blood-2021-148075
Published: 2021
Journal Articles

Increased Frequency of TOX + CD39 + TIGIT + CD73 - CD8 + T Cells in Patients with Newly Diagnosed AML

Franziska Brauneck, MD, Christin Ackermann, PhD, Nils Wildner, Jasmin Wellbrock, PhD, Carsten Bokemeyer, MD, Julian Schulze zur Wiesch, MD, Walter Fiedler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-139917
Published: 2020
Journal Articles

Mebendazole Mediates Its Anti-Leukemic Effects By Proteasomal Degradation of GLI Transcription Factors Via Inhibition of HSP70/90-Chaperone Activity in Acute Myeloid Leukemia in a Preclinical and Clinical Setting

Fabian Freisleben, Hauke Stamm, PhD, Jana Muschhammer, Vanessa Thaden, Franziska Modemann, MD, Alexander Krispien, Franziska Brauneck, Jasmin Wellbrock, PhD, Walter Fiedler, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5050.
https://doi.org/10.1182/blood-2019-129973
Published: 2019
Journal Articles

Identifying Immune Resistance Mechanisms to CD33/CD3 BiTE® Antibody Construct (AMG 330) Mediated Cytotoxicity

Christina Krupka, Thomas Köhnke, MD, Peter Kufer, Roman Kischel, Felix S. Lichtenegger, Franziska Brauneck, Stefan Rohling, Torben Altmann, Wolfgang Hiddemann, MD PhD, Marion S. Subklewe, MD
Journal: Blood
Blood (2015) 126 (23): 3677.
https://doi.org/10.1182/blood.V126.23.3677.3677
Published: 2015
Journal Articles

Hydroxyurea Is Most Suitable for Cytoreduction of AML Prior to CD33/CD3 Bispecific BiTE® Antibody (AMG 330) Therapy: Uncompromised T-Cell Proliferation Ex-Vivo and CD33 Upregulation on AML Cells

Christina Krupka, Franziska Brauneck, Felix S Lichtenegger, MD, Peter Kufer, MD, Roman Kischel, MD, Gerhard Zugmaier, Thomas Köhnke, MD, Torben Altmann, MD, Stephanie Schneider, PhD, Michael Fiegl, MD, Karsten Spiekermann, MD, Angus M Sinclair, PhD, Kathryn J Newhall, PhD, Stanley R Frankel, MD, Patrick Baeuerle, PhD, Wolfgang Hiddemann, MD, Gert Riethmüller, MD, Marion Subklewe, MD
Journal: Blood
Blood (2014) 124 (21): 986.
https://doi.org/10.1182/blood.V124.21.986.986
Published: 2014